Jeff and corporate are full of it.

Quote




Former employee here. Really respect Jeff, but have been following this launch and talking to friends who are still there. Yikes. It’s a dog. Really sorry to see what’s going on.
 



anonymous said:
This product does not work and they continue to blame everyone else. This is not the sales forces fault. This is a dog of a drug. Please stop the madness
Click to expand...

Let’s say the drug works…the copay card is more difficult to run than it’s worth, we have horrible marketing, new territories ans targets that are awful and no need in the market for the drug.
 












anonymous said:
It’s a hard sell. A lot of doctors aren’t buying in. 83.5% of patients chose a breakthrough medication. Is this study strong enough?
Click to expand...

No it’s not. And it’s borderline ethical when an important factor such as this is hidden (data on file with Kowa Pharmaceuticals). Managers asking reps to beg their friends for scripts. How is this sustainable?
 



anonymous said:
No it’s not. And it’s borderline ethical when an important factor such as this is hidden (data on file with Kowa Pharmaceuticals). Managers asking reps to beg their friends for scripts. How is this sustainable?
Click to expand...

also I don’t understand the direction of KOWA from a cardiology/internal centered company to calling on totally different space now. In the acute pain market. Who decided this!?
 












anonymous said:
No one does except for maybe Ben and Jeff. Best guess is Esteve paid KPA upfront to promote this shit drug.
Click to expand...
JM actually admitted on regional calls, “that given the climate, this isn’t an ideal time to launch an opioid.”
My God, loosen up his helmet & spray vinegar on the windows to keep him from licking.
 






Top Bottom
Back
Quote